{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:29:25Z","timestamp":1783816165755,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI Cancer Center","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.lungcan.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:56:42Z","timestamp":1520474202000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients"],"prefix":"10.1016","volume":"119","author":[{"given":"Simon R.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snjezana","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Arcila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2018.03.003_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","article-title":"Implementing genome-driven oncology","volume":"168","author":"Hyman","year":"2017","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.lungcan.2018.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.lungcan.2018.03.003_bib0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2018.03.003_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2018.03.003_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","article-title":"ROS1 rearrangements define a unique molecular class of lung cancers","volume":"30","author":"Bergethon","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7008","key":"10.1016\/j.lungcan.2018.03.003_bib0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/431525b","article-title":"Lung cancer: intragenic ERBB2 kinase mutations in tumours","volume":"431","author":"Stephens","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lungcan.2018.03.003_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/annonc\/mdv573","article-title":"Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort","volume":"27","author":"Mazi\u00e8res","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2015.11.006","article-title":"Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations","volume":"91","author":"Tissot","year":"2016","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2018.03.003_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/2159-8290.CD-14-1467","article-title":"Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping","volume":"5","author":"Paik","year":"2015","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.lungcan.2018.03.003_bib0050","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/annonc\/mdv186","article-title":"Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors","volume":"26","author":"Kris","year":"2015","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.03.003_bib0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2159-8290.CD-13-0035","article-title":"Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas","volume":"3","author":"Drilon","year":"2013","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.lungcan.2018.03.003_bib0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(16)00077-2","article-title":"Darafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial","volume":"17","author":"Planchard","year":"2016","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2018.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S1470-2045(16)30562-9","article-title":"Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial","volume":"17","author":"Drilon","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.03.003_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bjc.6602258","article-title":"The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis","volume":"92","author":"Mascaux","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2018.03.003_bib0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/JTO.0b013e318283d958","article-title":"KRAS mutations as prognostic and predictive markers in non-small cell lung cancer","volume":"8","author":"Martin","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.03.003_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/bjc.2015.215","article-title":"Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer","volume":"113","author":"J\u00e4nne","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.03.003_bib0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(12)70489-8","article-title":"Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study","volume":"14","author":"J\u00e4nne","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0090","series-title":"Routine Molecular Screening of Advanced Refractory Cancer Patients: An Analysis of the First 2490 Patients of the ProfilER Study. Paper Presented at the American Society of Clinical Oncology","author":"Tredan","year":"2017"},{"issue":"12","key":"10.1016\/j.lungcan.2018.03.003_bib0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.drudis.2015.08.005","article-title":"Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials","volume":"20","author":"Hyman","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.lungcan.2018.03.003_bib0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.lungcan.2018.03.003_bib0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.lungcan.2018.03.003_bib0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/JTO.0b013e31820517a3","article-title":"Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing","volume":"6","author":"Rekhtman","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2018.03.003_bib0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1078-0432.CCR-10-2277","article-title":"Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790\u202fM mutation using a locked nucleic acid-based assay","volume":"17","author":"Arcila","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.optechstcvs.2009.04.001","article-title":"Endobronchial ultrasound","volume":"4","author":"Crabtree","year":"2009","journal-title":"Oper. Tech. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thorsurg.2016.04.005","article-title":"Mediastinal staging: endosonographic ultrasound lymph node biopsy or mediastinoscopy","volume":"26","author":"Hegde","year":"2016","journal-title":"Thorac. Surg. Clin."},{"issue":"10","key":"10.1016\/j.lungcan.2018.03.003_bib0130","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/JTO.0b013e318153fd8d","article-title":"Endobronchial ultrasonography: current status and future directions","volume":"2","author":"Yasufuku","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.03.003_bib0135","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2011.08.037","article-title":"A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer","volume":"142","author":"Yasufuku","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2018.03.003_bib0140","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1378\/chest.15-0583","article-title":"Randomized trial of endobronchial ultrasound guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping","volume":"148","author":"Trisolini","year":"2015","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.lungcan.2018.03.003_bib0145","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.21037\/jtd.2016.08.74","article-title":"Cell block samples from endobronchial ultrasound transbronchial needle aspiration provide sufficient material for ancillary testing in lung cancer \u2013 a quaternary referral centre experience","volume":"8","author":"Hopkins","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.lungcan.2018.03.003_bib0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.07-0095","article-title":"Assessment of epidermal growth factor receptor mutation by endobronchial-ultrasound transbronchial needle aspiration","volume":"132","author":"Nakajima","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2018.03.003_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.humpath.2015.12.025","article-title":"A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping and multiple gene analyses in the majority of non-small cell cancer cases","volume":"51","author":"Rooper","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0160","article-title":"Feasibility of endobronchial ultrasound-guided transbronchial needle aspiration cytology specimens for next generation sequencing in non-small-cell lung cancer","author":"Stoy","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2018.03.003_bib0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/dc.23549","article-title":"Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: the Papanicoloau Society of Cytopathology consensus recommendations for respiratory cytology","volume":"44","author":"Layfield","year":"2016","journal-title":"Diagn. Cytopathol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.03.003_bib0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncy.21361","article-title":"Targeted next-generation using fine-needle aspirates from adenocarcinomas of the lung","volume":"122","author":"Karnes","year":"2013","journal-title":"Cancer Cytopathol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.03.003_bib0175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.5858\/arpa.2016-0108-RA","article-title":"Optimizing workflows and processing of cytologic samples for comprehensive analysis by next-generation sequencing: Memorial Sloan Kettering Cancer Center Experience","volume":"140","author":"Tian","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0180","article-title":"Novel modification to HistoGel-based cell block preparation method: improved sufficiency for molecular studies","author":"Rekhtman","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"12","key":"10.1016\/j.lungcan.2018.03.003_bib0185","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncy.21338","article-title":"Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms","volume":"121","author":"Young","year":"2013","journal-title":"Cancer Cytopathol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.03.003_bib0190","doi-asserted-by":"crossref","first-page":"e80478","DOI":"10.1371\/journal.pone.0080478","article-title":"Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel","volume":"8","author":"Scarpa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2018.03.003_bib0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/modpathol.2013.122","article-title":"Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics","volume":"27","author":"Kanagal-Shamanna","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.03.003_bib0200","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cncy.21597","article-title":"Factors affecting the success of next-generation sequencing in cytology specimens","volume":"123","author":"Roy-Chowdhuri","year":"2015","journal-title":"Cancer Cytopathol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218302800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218302800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T06:52:13Z","timestamp":1529995933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218302800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0169500218302800"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.03.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}